The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Open accessAbstract
Single-cell expression profiles of melanoma: Tumors harbor multiple cell types that are thought to play a role in the development of resistance to drug treatments. Tirosh et al. used single-cell sequencing to investigate the distribution of these differing genetic profiles within melanomas. Many cells harbored heterogeneous genetic programs that reflected two different states of genetic expression, one of which was linked to resistance development. Following drug treatment, the resistance-linked expression state was found at a much higher level. Furthermore, the environment of the melanoma cells affected their gene expression programs. Science , this issue p. 189
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SALL4-regulated genes showed a significant enrichment and positive correlation with published invasiveness signatures40–42, while they significantly anti-correlated with their corresponding proliferation signatures40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [42]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“among the SALL4-HDAC2 targets upregulated upon SALL4 knockdown, we found integrins (ITGB1, ITGA6, ITGA4), N-cadherin (CDH2), TGFBR2, VEGFR-1, PDGFC, LOXL2, MAPK8, and many others which are associated with invasive melanoma phenotypes40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [42]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Consistent with previous reports in mice 43 , the proportions of HSCs expressing G2/M/S-phase genes were enhanced upon IFNa treatment ( Fig. 2h,i) .”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“As IFNa has been shown to induce HSC and progenitors into cell cycle entry 43 , we posited that differential induction of progenitor subtypes into proliferation may underlie the shifts in differentiation.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [43]
Experimental — accuracy not yet measuredIn the citing paper
“Almost all previous work quantifying differences between single-cell datasets relies on discrete partitioning of the data before downstream analysis9–16.”
From Quantifying the effect of experimental perturbations at single-cell resolution (2021) · cites this paper as [11]
In the citing paper
“Cell cycle genes56 were excluded from this feature set and the dataset was subsetted to the resulting gene set.”
From Inferring and perturbing cell fate regulomes in human brain organoids (2023) · cites this paper as [56]
In the citing paper
“We used the union of the selected genes and TFs and further excluded cell-cycle-related genes56 from the set.”
From Inferring and perturbing cell fate regulomes in human brain organoids (2023) · cites this paper as [56]
In the citing paper
“Through deconvolution of complex samples30, such as tumor biopsies35, one may infer their cellular milieu, and characterize the rare5, functionally important1, and unknown36 cell types they contain.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [35]
In the citing paper
“Several studies inferred the cell cycle phase of individual cells from single-cell RNA-seq data30,35,97,99, relying on transcriptional signatures of discrete phases from earlier bulk profiling experiments146.”
From Revealing the vectors of cellular identity with single-cell genomics (2016) · cites this paper as [35]
In the citing paper
“We performed latent variable regression to mitigate heterogeneity resulting from cell-cycle state10,11 (Extended Data Fig. 1), preventing subsequent analysis from being dominated by mitotic phase-specific gene expression”
From Developmental diversification of cortical inhibitory interneurons (2018) · cites this paper as [11]
In the citing paper
“In parallel, methods to measure the transcriptomes of single cells have been used to discover new cell types11 and new functional cell states12,13, and provide additional motivation for the development of tools to measure chromatin regulation at single-cell resolution14.”
From Droplet-based combinatorial indexing for massive-scale single-cell chromatin accessibility (2019) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
(2008) · Journal of Machine Learning Research · Cited by 33,051
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
(1996) · Cited by 20,179
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay‐Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,320
Flagged first, then by citations
Cited by
Sorted by citations
Items 901–1,000 of 1,033
FOXOs in cancer immunity: Knowns and unknowns
Deng, Y., Wang, F., Hughes, T. L., & Yu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.005 · Cited by 84
Self-citationCirculating CD56bright NK cells inversely correlate with survival of melanoma patients
de Jonge, K., Ebering, A., Nassiri, S., Hajjami, H. M.-E., Ouertatani-Sakouhi, H., Baumgaertner, P., & Speiser, D. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-40933-8 · Cited by 82
Single-cell sequencing and its applications in head and neck cancer
Qi, Z., Barrett, T. F., Parikh, A. S., Tirosh, I., & Puram, S. V. (2019) · Oral Oncology · doi:10.1016/j.oraloncology.2019.104441 · Cited by 82
Self-citationAkhmedov, M., Martinelli, A., Geiger, R., & Kwee, I. (2019) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqz019 · Cited by 82
Ding, Z., Shi, H., Aboelella, N. S., Fesenkova, K., Park, E.-J., Liu, Z., Pei, L., Li, J., McIndoe, R., Xu, H., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.aba5962 · Cited by 82
Valdés‐Mora, F., Salomon, R., Gloss, B., Law, A. M. K., Venhuizen, J., Castillo, L. E., Murphy, K. J., Magenau, A., Papanicolaou, M., de la Fuente, L. R., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108945 · Cited by 82
Wu, W., Liu, Y., Zeng, S., Han, Y., & Shen, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01166-3 · Cited by 83
Differentiation route determines the functional outputs of adult megakaryopoiesis
Li, J., Liu, J., Li, Y., Chen, L. V., Cheng, H., Li, Y., Cheng, T., Wang, Q., & Zhou, B. O. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.006 · Cited by 82
Raaijmakers, M. I. G., Widmer, D. S., Narechania, A., Eichhoff, O. M., Freiberger, S. N., Wenzina, J., Cheng, P. F., Mihic‐Probst, D., DeSalle, R., Dummer, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12848 · Cited by 82
Indicators of responsiveness to immune checkpoint inhibitors
Shields, B. D., Mahmoud, F. A., Taylor, E. M., Byrum, S. D., Sengupta, D., Koss, B. S., Baldini, G., Ransom, S. C., Cline, K., Mackintosh, S. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01000-2 · Cited by 81
van den Heuvel, A., Mahfouz, A. E., Kloet, S. L., Balog, J., van Engelen, B. G. M., Tawil, R., Tapscott, S. J., & van der Maarel, S. M. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy400 · Cited by 81
MITF controls the TCA cycle to modulate the melanoma hypoxia response
Louphrasitthiphol, P., Ledaki, I., Chauhan, J. S., Falletta, P., Siddaway, R., Buffa, F. M., Mole, D. R., Soga, T., & Goding, C. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12802 · Cited by 82
Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells
Lucca, L. E., Axisa, P., Lu, B. Y., Harnett, B., Jessel, S., Zhang, L., Raddassi, K., Zhang, L., Olino, K. L., Clune, J. E., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200921 · Cited by 81
Herrera, A. M., Cheng, A., Mimitou, E. P., Seffens, A., George, D. D., Bar‐Natan, M., Heguy, A., Ruggles, K. V., Scher, J. U., Hymes, K. B., et al. (2021) · Blood · doi:10.1182/blood.2020009346 · Cited by 81
Hou, S., Li, Z., Dong, J., Gao, Y., Chang, Z., Ding, X., Li, S., Li, Y., Zeng, Y., Qian, X., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00615-z · Cited by 81
Understanding Drug Sensitivity and Tackling Resistance in Cancer
Tyner, J. W., Haderk, F., Kumaraswamy, A., Baughn, L. B., Ness, B. V., Liu, S., Marathe, H., Alumkal, J. J., Bivona, T. G., Chan, K. S., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3695 · Cited by 81
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Cao, S., Wang, J. R., Ji, S., Peng, Y., Dai, Y., Guo, S., Montierth, M. D., Shen, J. P., Zhao, X. H., Chen, J., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01342-x · Cited by 81
Roider, T., Baertsch, M., Fitzgerald, D., Vöhringer, H. S., Brinkmann, B. J., Czernilofsky, F., Knoll, M., Cid, L. L., Mathioudaki, A., Faßbender, B., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01358-2 · Cited by 81
mTOR Signaling Confers Resistance to Targeted Cancer Drugs
Guri, Y., & Hall, M. N. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.10.006 · Cited by 81
In vitro reconstitution of epigenetic reprogramming in the human germ line
Murase, Y., Yokogawa, R., Yabuta, Y., Nagano, M., Katou, Y., Mizuyama, M., Kitamura, A., Puangsricharoen, P., Yamashiro, C., Hu, B., et al. (2024) · Nature · doi:10.1038/s41586-024-07526-6 · Cited by 80
Morelli, E., Biamonte, L., Federico, C., Amodio, N., Martino, M. T. D., Cantafio, M. E. G., Manzoni, M., Scionti, F., Samur, M., Gullà, A., et al. (2018) · Blood · doi:10.1182/blood-2018-03-836601 · Cited by 80
The Role of Immune Checkpoint Blockade in Uveal Melanoma
Wessely, A., Steeb, T., Erdmann, M., Heinzerling, L., Vera, J., Schlaak, M. S., Berking, C., & Heppt, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030879 · Cited by 80
Immunology in the Era of Single-Cell Technologies
Efremova, M., Vento‐Tormo, R., Park, J.-E., Teichmann, S. A., & James, K. R. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-090419-020340 · Cited by 80
Pan-Cancer Analysis of Ligand–Receptor Cross-talk in the Tumor Microenvironment
Ghoshdastider, U., Rohatgi, N., Naeini, M. M., Baruah, P., Revkov, E., Guo, Y. A., Rizzetto, S., Wong, A. M. L., Solai, S., Nguyen, T. T., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2352 · Cited by 80
Comparative single-cell analysis of biopsies clarifies pathogenic mechanisms in Klinefelter syndrome
Mahyari, E., Guo, J., Lima, A. C., Lewinsohn, D. P., Stendahl, A. M., Vigh‐Conrad, K. A., Nie, X., Nagirnaja, L., Rockweiler, N. B., Carrell, D. T., et al. (2021) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2021.09.001 · Cited by 80
Chiara, L. D., Conte, C., Semeraro, R., Díaz-Bulnes, P., Angelotti, M. L., Mazzinghi, B., Molli, A., Antonelli, G., Landini, S., Melica, M. E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33110-5 · Cited by 80
A single-cell massively parallel reporter assay detects cell-type-specific gene regulation
Zhao, S., Hong, C. K., Myers, C. A., Granas, D. M., White, M. A., Corbo, J. C., & Cohen, B. A. (2023) · Nature Genetics · doi:10.1038/s41588-022-01278-7 · Cited by 80
Liu, X., Wang, X. M., Yang, Q., Luo, L., Liu, Z., Ren, X., Lei, K., Li, S., Xie, Z., Zheng, G., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2123 · Cited by 80
Ryu, D., Kim, S. J., Hong, Y., Jo, A., Kim, N., Kim, H., Lee, H., Kım, K., & Park, W. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0694 · Cited by 80
Spatiotemporally resolved transcriptomics reveals the subcellular RNA kinetic landscape
Ren, J., Zhou, H., Zeng, H., Wang, C. K., Huang, J., Qiu, X., Sui, X., Li, Q., Wu, X., Lin, Z., et al. (2023) · Nature Methods · doi:10.1038/s41592-023-01829-8 · Cited by 79
Li, G., Tian, L., Goodyer, W. R., Kort, E. J., Buikema, J. W., Xu, A., Wu, J. C., Jovinge, S. V., & Wu, S. M. (2019) · Development · doi:10.1242/dev.173476 · Cited by 79
Bilate, A. M. B., London, M., Castro, T. B. R., Mesin, L., Bortolatto, J., Kongthong, S., Harnagel, A., Victora, G. D., & Mucida, D. (2020) · Immunity · doi:10.1016/j.immuni.2020.09.003 · Cited by 79
Brägelmann, J., Lorenz, C., Borchmann, S., Nishii, K., Wegner, J., Meder, L., Ostendorp, J., Ast, D., Heimsoeth, A., Nakasuka, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25728-8 · Cited by 79
Ennen, M., Keime, C., Gambi, G., Kieny, A., Coassolo, S., Thibault-Carpentier, C., Margerin-Schaller, F., Davidson, G., Vagne, C., Lipsker, D. M., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0010 · Cited by 79
Poirion, O., Zhu, X., Ching, T. H., & Garmire, L. X. (2018) · Nature Communications · doi:10.1038/s41467-018-07170-5 · Cited by 79
Roux, A. E., Zhang, C., Paw, J., Zavala-Solorio, J., Malahias, E., Vijay, T., Kolumam, G., Kenyon, C., & Kimmel, J. C. (2022) · Cell Systems · doi:10.1016/j.cels.2022.05.002 · Cited by 78
Wang, Y., Fang, Z., Hong, M., Yang, D., & Xie, W. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.09.011 · Cited by 78
Cardelino: computational integration of somatic clonal substructure and single-cell transcriptomes
McCarthy, D. J., Rostom, R., Huang, Y., Kunz, D. J., Danecek, P., Bonder, M. J., Hagai, T., Lyu, R., Wang, W., Gaffney, D. J., et al. (2020) · Nature Methods · doi:10.1038/s41592-020-0766-3 · Cited by 78
Strategies to target long non-coding RNAs in cancer treatment: progress and challenges
Dizaji, B. F. (2020) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-020-00074-4 · Cited by 78
Blavier, L., Yang, R.-M., & DeClerck, Y. A. (2020) · Cancers · doi:10.3390/cancers12102912 · Cited by 78
Zhou, S., Huang, Y., Liu, H., Zhou, X., Yuan, M., Hou, F., Wang, L., & Jiang, W. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.018 · Cited by 78
Melanoma dedifferentiation induced by IFN-γ epigenetic remodeling in response to anti–PD-1 therapy
Kim, Y. J., Sheu, K. M., Tsoi, J., Abril-Rodríguez, G., Medina, E., Grasso, C. S., Torrejon, D. Y., Champhekar, A. S., Litchfield, K., Swanton, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145859 · Cited by 79
Dissecting metastasis using preclinical models and methods
Hebert, J. D., Neal, J. W., & Winslow, M. M. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00568-4 · Cited by 78
Wang, Y., Tong, C., Lu, Y., Wu, Z., Guo, Y., Liu, Y., Wei, J., Wang, C., Yang, Q., & Han, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01659-2 · Cited by 81
From biomarkers to therapeutic targets—the promises and perils of long non-coding RNAs in cancer
Gutschner, T., Richtig, G., Haemmerle, M., & Pichler, M. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9718-5 · Cited by 78
STRT-seq-2i: dual-index 5ʹ single cell and nucleus RNA-seq on an addressable microwell array
Hochgerner, H., Lönnerberg, P., Hodge, R. D., Mikeš, J., Heskol, A., Hubschle, H., Lin, P., Picelli, S., Manno, G. L., Ratz, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16546-4 · Cited by 78
Co-Stimulatory Receptors in Cancers and Their Implications for Cancer Immunotherapy
Jeong, S., & Park, S. (2020) · Immune Network · doi:10.4110/in.2020.20.e3 · Cited by 78
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle
Cheng, W.-C., Tsui, Y., Ragusa, S., Koelzer, V. H., Mina, M., Franco, F., Laubli, H. P., Tschumi, B., Speiser, D. E., Romero, P. J., et al. (2019) · Nature Immunology · doi:10.1038/s41590-018-0290-0 · Cited by 77
Wegmann, R., Neri, M., Schuierer, S., Bilican, B., Hartkopf, H., Nigsch, F., Mapa, F., Waldt, A., Cuttat, R., Salick, M. R., et al. (2019) · Genome biology · doi:10.1186/s13059-019-1739-7 · Cited by 77
Tumor diversity and the trade-off between universal cancer tasks
Hausser, J., Székely, P., Bar, N., Zimmer, A., Sheftel, H., Caldas, C., & Alon, U. (2019) · Nature Communications · doi:10.1038/s41467-019-13195-1 · Cited by 78
Kelly, N. H., Huynh, N. P. T., & Guilak, F. (2019) · Matrix Biology · doi:10.1016/j.matbio.2019.12.004 · Cited by 77
Spatiotemporal Analysis Reveals Overlap of Key Proepicardial Markers in the Developing Murine Heart
Lupu, I.-E., Redpath, A. N., & Smart, N. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.04.002 · Cited by 77
Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors
Cui, Y., Li, C., Zhen-huan, J., Zhang, S., Li, Q., Liu, X., Zhou, Y., Li, R., Wei, L., Li, L., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab102 · Cited by 77
Computational immunogenomic approaches to predict response to cancer immunotherapies
Addala, V., Newell, F., Pearson, J. V., Redwood, A., Robinson, B. W. S., Creaney, J., & Waddell, N. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00830-6 · Cited by 79
He, S., Jin, Y., Nazaret, A., Shi, L., Chen, X., Rampersaud, S., Dhillon, B. S., Valdez, I. K., Friend, L. E., Fan, J. L., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02173-8 · Cited by 77
Measuring intratumor heterogeneity by network entropy using RNA-seq data
Park, Y., Lim, S., Nam, J., & Kim, S. (2016) · Scientific Reports · doi:10.1038/srep37767 · Cited by 77
Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure
Smith, M. P., Rowling, E. J., Miskolczi, Z., Ferguson, J., Spoerri, L., Haass, N. K., Sloss, O., McEntegart, S., Arozarena, I., von Kriegsheim, A., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607156 · Cited by 77
Self-citationMorrison, J. A., McLennan, R., Wolfe, L. A., Gogol, M., Meier, S. R., McKinney, M. C., Teddy, J. M., Holmes, L., Semerad, C. L., Box, A., et al. (2017) · eLife · doi:10.7554/elife.28415 · Cited by 77
Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
Finotello, F., & Eduati, F. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00430 · Cited by 77
McImpute: Matrix Completion Based Imputation for Single Cell RNA-seq Data
Mongia, A., Sengupta, D., & Majumdar, A. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00009 · Cited by 77
Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing
Zhang, L., & Zhang, Z. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0658 · Cited by 77
Wong, P. F., Wei, W., Gupta, S., Smithy, J. W., Zelterman, D. A., Kluger, H. M., & Rimm, D. L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0675-0 · Cited by 77
Wang, L., Fan, J., Francis, J. M., Georghiou, G. P., Hergert, S., Li, S., Gambe, R. G., Zhou, C. W., Yang, C., Xiao, S., et al. (2017) · Genome Research · doi:10.1101/gr.217331.116 · Cited by 77
Nayler, S., Agarwal, D., Curion, F., Bowden, R. J., & Becker, E. B. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-91846-4 · Cited by 76
Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection
Wang, X., Zhang, J., Xing, X., Huang, H.-H., Xia, P., Dai, X., Hu, W., Zhang, C., Song, J., Fan, X., et al. (2022) · Cell Discovery · doi:10.1038/s41421-021-00367-x · Cited by 76
An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2
Barnett, K. C., Xie, Y., Asakura, T., Song, D., Liang, K., Taft-Benz, S., Guo, H., Yang, S., Okuda, K., Gilmore, R. C., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.12.005 · Cited by 78
Battistello, E., Hixon, K., Comstock, D. E., Collings, C. K., Chen, X., Rodriguez-Hernaez, J., Lee, S., Cervantes, K. S., Hinkley, M. M., Ntatsoulis, K., et al. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.02.026 · Cited by 78
Tian, D., Qin, C., Dong, M., Heming, M., Zhou, L., Wang, W., Cai, S.-B., You, Y., Shang, K., Xiao, J., et al. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00043-z · Cited by 76
Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases
Tagore, S., Caprio, L., Amin, A. D., Bestak, K., Luthria, K. D., D’Souza, E. K., Barrera, I., Melms, J. C., Wu, S., Abuzaid, S., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03530-z · Cited by 80
Self-citationMapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq
Gerber, T., Willscher, E., Loeffler‐Wirth, H., Hopp, L., Schadendorf, D., Schartl, M., Anderegg, U., Camp, J. G., Treutlein, B., Binder, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13666 · Cited by 76
Xie, J., Ma, A., Zhang, Y., Liu, B., Cao, S., Wang, C., Xu, J., Zhang, C., & Ma, Q. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz692 · Cited by 76
Mapping the multiscale structure of biological systems
Schaffer, L. V., & Ideker, T. (2021) · Cell Systems · doi:10.1016/j.cels.2021.05.012 · Cited by 75
Nie, Y., He, J., Shirota, H., Trivett, A. L., Yang, D., Klinman, D. M., Oppenheim, J. J., & Chen, X. (2018) · Science Signaling · doi:10.1126/scisignal.aan0790 · Cited by 75
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma
Webster, M. R., Fane, M. E., Alicea, G. M., Basu, S., Kossenkov, A. V., Marino, G. E., Douglass, S. M., Kaur, A., Ecker, B. L., Gnanapradeepan, K., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.11.009 · Cited by 75
Consistent RNA sequencing contamination in GTEx and other data sets
Nieuwenhuis, T. O., Yang, S. Y., Verma, R., Pillalamarri, V., Arking, D. E., Rosenberg, A. Z., McCall, M. N., & Halushka, M. K. (2020) · Nature Communications · doi:10.1038/s41467-020-15821-9 · Cited by 75
Borrett, M. J., Innes, B. T., Jeong, D., Tahmasian, N., Storer, M. A., Bader, G. D., Kaplan, D. R., & Miller, F. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108022 · Cited by 75
Wu, C.-Y., Lau, B. T., Kim, H. S., Sathe, A., Grimes, S. M., Ji, H. P., & Zhang, N. R. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00911-w · Cited by 75
Granhøj, J. S., Jensen, A. W. P., Presti, M., Met, Ö., Svane, I. M., & Donia, M. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2064711 · Cited by 76
Metacells untangle large and complex single-cell transcriptome networks
Bilous, M., Tran, L., Cianciaruso, C., Gabriel, A. A., Michel, H., Carmona, S. J., Pittet, M. J., & Gfeller, D. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04861-1 · Cited by 75
Yun, J., Hansen, S., Morris, O., Madden, D. T., Libeu, C. P., Kumar, A. J., Wehrfritz, C., Nile, A. H., Zhang, Y., Zhou, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35487-9 · Cited by 75
Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages
Gonzalez, M. A., Lu, D., Yousefi, M., Kroll, A. V., Lo, C. H., Briseño, C. G., Watson, J. E. V., Novitskiy, S. V., Arias, V., Zhou, H., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221472 · Cited by 75
Self-citationSingle‐cell dissection of cervical cancer reveals key subsets of the tumor immune microenvironment
Cao, G., Yue, J., Ruan, Y., Han, Y., Zhi, Y., Lu, J., Liu, M., Xu, X., Wang, J., Gu, Q., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022110757 · Cited by 75
Wu, Z., Gao, S., Gao, Q., Patel, B. A., Groarke, E. M., Feng, X., Manley, A. L., Li, H., Cardona, D. O., Kajigaya, S., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101160 · Cited by 75
Sctensor detects many-to-many cell–cell interactions from single cell RNA-sequencing data
Tsuyuzaki, K., Ishii, M., & Nikaido, I. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05490-y · Cited by 77
Xie, X., Wang, P., Jin, M., Wang, Y., Qi, L., Wu, C., Guo, S., Li, C., Zhang, X., Yuan, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53307-0 · Cited by 75
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Davar, D., Morrison, R. M., Dzutsev, A., Karunamurthy, A. D., Chauvin, J.-M., Amatore, F., Deutsch, J. S., das Neves, R. X., Rodrigues, R. R., McCulloch, J. A., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.10.007 · Cited by 75
Craig, M., Jenner, A. L., Namgung, B., Lee, L. P., & Goldman, A. J. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00356 · Cited by 74
Bondeson, D. P., Paolella, B. R., Asfaw, A., Rothberg, M. V., Skipper, T. A., Langan, C. R., Mesa, G., Gonzalez, A. E., Surface, L. E., Ito, K., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00360-7 · Cited by 74
Trends and Potential of Machine Learning and Deep Learning in Drug Study at Single-Cell Level
Qi, R., & Zou, Q. (2023) · Research · doi:10.34133/research.0050 · Cited by 74
Tillé, L., Cropp, D., Charmoy, M., Reichenbach, P., Andreatta, M., Wyss, T., Bodley, G., Crespo, I., Nassiri, S., Lourenço, J., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01614-x · Cited by 74
Kim, D. J., Dunleavey, J. M., Xiao, L., Ollila, D. W., Troester, M. A., Otey, C. A., Li, W., Barker, T. H., & Dudley, A. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0072-3 · Cited by 74
Wu, Y., Tamayo, P., & Zhang, K. (2018) · Cell Systems · doi:10.1016/j.cels.2018.10.015 · Cited by 74
A statistical simulator scDesign for rational scRNA-seq experimental design
Li, W. V., & Li, J. J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz321 · Cited by 74
Wang, X., Lü, Y., Song, Y., Dong, J., Li, R., Wang, G., Wang, X., Zhang, S., Dong, Z., Lu, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14601-9 · Cited by 76
Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-23-0913 · Cited by 73
Exhausted T cells and epigenetic status
Zeng, Z., Wei, F., & Ren, X. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0338 · Cited by 73
Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer
Xin, G., Yao, C., Topchyan, P., Kasmani, M. Y., Burns, R., Volberding, P. J., Wu, X., Cohn, A., Chen, Y., Lin, C., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0433 · Cited by 73
Boshuizen, J., Pencheva, N., Krijgsman, O., Altimari, D. M. D., Castro, P. G., de Bruijn, B., Ligtenberg, M. A., den Heuvel, E. G.-V., Vredevoogd, D. W., Song, J., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0434 · Cited by 73
Bonnal, R. J. P., Rossetti, G., Lugli, E., Simone, M. C. D., Gruarin, P., Brummelman, J., Drufuca, L., Passaro, M., Bason, R., Gervasoni, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00930-4 · Cited by 73
Diener, J., & Sommer, L. (2021) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0351 · Cited by 64
Metadata
- Authors
- Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., Fallahi-Sichani, M., Dutton-Regester, K., Lin, J.-R., Cohen, O., Shah, P., Lu, D., Genshaft, A. S., Hughes, T. K., Ziegler, C. G. K., Kazer, S. W., Gaillard, A., Kolb, K. E., Villani, A.-C., Johannessen, C. M., Andreev, A. Y., Van Allen, E. M., Bertagnolli, M., Sorger, P. K., Sullivan, R. J., Flaherty, K. T., Frederick, D. T., Jané-Valbuena, J., Yoon, C. H., Rozenblatt-Rosen, O., Shalek, A. K., Regev, A., & Garraway, L. A.
- Affiliations
- Broad Institute (US)
- Brigham and Women's Hospital (US)
- Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Program in Therapeutic Sciences, Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
- Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
- Harvard University (US)
- Massachusetts General Hospital (US)
- Corresponding author
- Tirosh, Itay
- Izar, Benjamin
- Yoon, Charles H.
- Shalek, Alex K.
- Regev, Aviv
- Garraway, Levi A.
- ORCID
- Tirosh, Itay
- Izar, Benjamin
- Prakadan, Sanjay M.
- Wadsworth, Marc H.
- Rotem, Asaf
- Rodman, Christopher
- Lian, Christine
- Lin, Jia-Ren
- Cohen, Ofir
- Shah, Parin
- Genshaft, Alex S.
- Hughes, Travis K.
- Ziegler, Carly G. K.
- Kazer, Samuel W.
- Kolb, Kellie E.
- Villani, Alexandra-Chloé
- Johannessen, Cory M.
- Bertagnolli, Monica
- Sorger, Peter K.
- Sullivan, Ryan J.
- Flaherty, Keith T.
- Frederick, Dennie T.
- Yoon, Charles H.
- Shalek, Alex K.
- Regev, Aviv
- Garraway, Levi A.
- Venue
- Science
- Published
- 2016-04-08
- Volume
- 352
- Issue
- 6282
- Pages
- 189-196
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC4944528
- OpenAlex
- W2332292689
- Cited by
- 4,944
- References
- 70
- Citations by year
- 2026: 546 · 2025: 629 · 2024: 633 · 2023: 606 · 2022: 582 · 2021: 608 · 2020: 486 · 2019: 336 · 2018: 265 · 2017: 195 · 2016: 41
- FWCI
- 145.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- National Cancer Institute (NCI) (P01CA163222, R35CA197737)
- Dr. Miriam and Sheldon Adelson Medical Research Foundation
- Melanoma Research Alliance
- Ludwig Center at Harvard Medical School
- Howard Hughes Medicine Institute
- Klarman Cell Observatory
- STARR Cancer Consortium
- Broad Institute
- Searle Scholars Program
- Beckman Young Investigator Program
- Dana-Farber Cancer Institute
- Human Frontier Science Program
- Integrative Cancer Biology Program (U54CA112962)
- NCI (1U24CA180922, P30-CA14051, K99CA194163)
- NIH (DP2 OD020839, P50GM107618)
- Ludwig Center at Harvard
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Keywords
- metastatic melanoma, tumor microenvironment, tumor heterogeneity, MITF, AXL kinase, drug resistance, tumor-infiltrating T cells, T cell exhaustion, clonal expansion, tumor stroma, endothelial cells, cell-cell interactions, immunotherapy
- MeSH terms
- Base Sequence, Cell Communication, Cell Cycle, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Neoplasm Metastasis, RNA, Skin Neoplasms, T-Lymphocytes, Stromal Cells, Sequence Analysis, RNA, Drug Resistance, Neoplasm, Genomics, Endothelial Cells, Microphthalmia-Associated Transcription Factor, Single-Cell Analysis, Tumor Microenvironment, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
